Search Orphan Drug Designations and Approvals
-
Generic Name: | 3-[5-[(1R)-1-[bis(aziridin-1-yl(phosphoryloxy]ethyl]-2-nitrophenoxy]-N,N-dimethylbenzamide |
---|---|
Date Designated: | 09/17/2018 |
Orphan Designation: | Treatment of Acute Lymphoblastic Leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
OBI Pharma USA, Inc. 6020 Cornerstone Court W, Suite 200 San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-